|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5219564A
(en)
*
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
WO2004002455A1
(en)
*
|
2002-06-26 |
2004-01-08 |
Medigene Oncology Gmbh |
Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
US20050142581A1
(en)
|
2003-09-04 |
2005-06-30 |
Griffey Richard H. |
Microrna as ligands and target molecules
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
US20080213891A1
(en)
|
2004-07-21 |
2008-09-04 |
Alnylam Pharmaceuticals, Inc. |
RNAi Agents Comprising Universal Nucleobases
|
|
AU2005328382C1
(en)
|
2004-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
CA2574603C
(en)
|
2004-08-04 |
2014-11-04 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
|
|
WO2007021896A2
(en)
|
2005-08-10 |
2007-02-22 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
WO2007027894A2
(en)
|
2005-08-29 |
2007-03-08 |
Isis Pharmaceuticals, Inc. |
Antisense compounds having enhanced anti-microrna activity
|
|
CA2620856C
(en)
|
2005-08-29 |
2017-11-28 |
Isis Pharmaceuticals, Inc. |
Methods for use in modulating mir-122a
|
|
EP1984499B1
(en)
|
2006-01-27 |
2015-05-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of micrornas
|
|
EP2666859B1
(en)
|
2006-04-03 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
CA2648132C
(en)
|
2006-04-03 |
2019-05-28 |
Santaris Pharma A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
WO2008046911A2
(en)
|
2006-10-20 |
2008-04-24 |
Exiqon A/S |
Novel human micrornas associated with cancer
|
|
US20090137504A1
(en)
|
2006-12-21 |
2009-05-28 |
Soren Morgenthaler Echwald |
Microrna target site blocking oligos and uses thereof
|
|
WO2008113832A2
(en)
|
2007-03-22 |
2008-09-25 |
Santaris Pharma A/S |
SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF TARGET mRNA
|
|
EP2623599B1
(en)
|
2007-10-04 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Micromirs
|
|
US20090156459A1
(en)
*
|
2007-11-16 |
2009-06-18 |
Pharmain Corporation |
Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
US8541435B2
(en)
*
|
2008-07-11 |
2013-09-24 |
Uday Saxena |
Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
|
|
JP5622254B2
(ja)
*
|
2009-03-31 |
2014-11-12 |
国立大学法人東京大学 |
二本鎖リボ核酸ポリイオンコンプレックス
|
|
ES2599979T3
(es)
|
2009-04-24 |
2017-02-06 |
Roche Innovation Center Copenhagen A/S |
Composiciones farmacéuticas para el tratamiento de pacientes de VHC que no responden al interferón
|
|
CN102573913B
(zh)
*
|
2009-07-31 |
2014-06-18 |
阿森迪斯药物股份有限公司 |
可生物降解的基于聚乙二醇的水不溶性水凝胶
|
|
CA2773737C
(en)
*
|
2009-09-09 |
2021-11-16 |
Pharmain Corporation |
Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
|
|
US20120005765A1
(en)
*
|
2010-07-01 |
2012-01-05 |
Saint Louis University |
Animal model for parkinson's disease
|
|
BR112013006686A2
(pt)
|
2010-09-24 |
2017-11-14 |
Zoetis Llc |
isoxazolina oximas como agentes antiparasitários
|
|
EP2741780A1
(en)
*
|
2011-08-10 |
2014-06-18 |
Ludwig-Maximilians-Universität München |
Method for the controlled intracellular delivery of nucleic acids
|
|
JP6646578B2
(ja)
*
|
2013-12-05 |
2020-02-14 |
ウー, ニエンWU, Nian |
薬物転送技術のための高分子−炭水化物共役体
|
|
KR20170003527A
(ko)
*
|
2014-02-24 |
2017-01-09 |
유리젠 파마슈티컬스, 인코포레이티드 |
경구 투여용 펜토산 폴리설페이트 염의 조성물
|
|
US20180334732A1
(en)
*
|
2014-11-25 |
2018-11-22 |
Drexel University |
Compositions and methods for hiv quasi-species excision from hiv-1-infected patients
|
|
CN108289906B
(zh)
*
|
2015-11-19 |
2022-03-11 |
公立大学法人名古屋市立大学 |
抗肿瘤性药物递送制剂
|
|
WO2017212007A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Curevac Ag |
Cationic carriers for nucleic acid delivery
|
|
WO2018053316A1
(en)
|
2016-09-15 |
2018-03-22 |
The Regents Of The University Of California |
Improved hybrid telodendrimers
|
|
RU2016146594A
(ru)
*
|
2016-11-28 |
2018-05-28 |
Общество С Ограниченной Ответственностью "Биофарм-Меморейн" |
Средство для лечения деменции различной этиологии
|
|
CN110582301A
(zh)
|
2016-12-14 |
2019-12-17 |
利甘达尔股份有限公司 |
用于核酸和蛋白质有效负载递送的方法和组合物
|
|
WO2018139759A1
(ko)
*
|
2017-01-26 |
2018-08-02 |
주식회사 바이오오케스트라 |
마이크로 rna를 이용한 알츠하이머병 진단방법
|
|
US11123304B2
(en)
|
2017-02-03 |
2021-09-21 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
|
|
CN110156971A
(zh)
|
2018-02-13 |
2019-08-23 |
上海时莱生物技术有限公司 |
一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统
|
|
US11857634B2
(en)
|
2018-04-20 |
2024-01-02 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
|
|
CN111632153B
(zh)
|
2020-06-23 |
2023-02-24 |
宁夏医科大学 |
一种化学基因药物共载的靶向纳米递药系统及其制备方法
|
|
CA3200622A1
(en)
|
2020-12-30 |
2022-07-07 |
Jin-Hyeob RYU |
Micellar nanoparticles and uses thereof
|
|
JP2024503303A
(ja)
|
2020-12-30 |
2024-01-25 |
バイオーケストラ カンパニー， リミテッド |
ミセルナノ粒子及びその使用
|